| |
| |
|
| Insider
Information: |
Fanucci Marsha |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
180,249 |
|
|
Indirect Shares
|
5,217 |
|
|
| Direct
Value |
$1,655,439 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
185,466 |
|
|
| Total
Value |
$1,655,439 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Millennium Pharmaceuticals Inc |
MLNM |
SVP, Chief Financial O... |
2008-05-14 |
0 |
2008-03-11 |
5,217 |
Premium* |
|
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2019-04-01 |
132,663 |
|
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2016-06-23 |
14,500 |
2013-03-15 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2023-02-23 |
136 |
2015-02-25 |
0 |
Premium* |
|
|
Cyclerion Therapeutics, Inc. |
CYCN |
Director |
2019-04-01 |
16,950 |
2019-04-01 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director |
2022-10-14 |
0 |
|
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
|
2024-06-05 |
16,000 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MLNM |
Millennium Pharmaceutical... |
Chief Financial OfficerOfficer |
• – – |
2004-07-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,151 |
|
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2010-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
44,863 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
26,547 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,325 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,332 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,628 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2023-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
136 |
136 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
55,282 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2008-05-09 |
4 |
D |
$25.00 |
$81,750 |
D/D |
(3,270) |
109,514 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
12,000 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
|
– • – |
2024-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
16,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2019-04-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,056) |
132,663 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2007-03-12 |
4 |
AS |
$10.64 |
$45,167 |
D/D |
(4,245) |
92,982 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2008-03-11 |
4 |
AS |
$12.82 |
$56,780 |
D/D |
(4,429) |
112,784 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2008-02-29 |
4 |
AS |
$13.68 |
$74,940 |
D/D |
(5,480) |
123,202 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2016-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
14,500 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2008-03-07 |
4 |
AS |
$13.34 |
$79,891 |
D/D |
(5,989) |
117,213 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2007-03-08 |
4 |
AS |
$10.41 |
$64,261 |
D/D |
(6,173) |
97,227 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2007-09-19 |
4 |
AS |
$10.67 |
$79,342 |
D/D |
(7,436) |
75,482 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2007-02-06 |
4 |
AS |
$11.17 |
$83,741 |
D/D |
(7,497) |
59,170 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,339 |
31,339 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2015-02-25 |
4 |
AS |
$104.83 |
$1,057,953 |
D/D |
(10,000) |
0 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2006-09-18 |
4 |
AS |
$10.95 |
$109,533 |
D/D |
(10,003) |
66,667 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
SVP, Chief Financial Officer |
• – – |
2007-09-18 |
4 |
AS |
$10.58 |
$106,477 |
D/D |
(10,064) |
82,918 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
